Role of chemotherapy in the management of vulvar carcinoma

Critical Reviews in Oncology/Hematology

Volumn 82, Issue 1, 2012, Pages 25-39

  Tomao, Federica ^a   Di Tucci, Chiara ^a   Marchetti, Claudia ^a   Perniola, Giorgia ^a   Bellati, Filippo ^a   Panici, Pierluigi Benedetti ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemotherapy; Squamous vulvar cancer

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; CETUXIMAB; CISPLATIN; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; GEFITINIB; LOMUSTINE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; TOPOTECAN; VINCRISTINE; WART VIRUS VACCINE;

ADJUVANT THERAPY; BONE MARROW SUPPRESSION; BONE NECROSIS; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CHEMOSENSITIVITY; CONTINUOUS INFUSION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG FATALITY; DRUG UTILIZATION; ENTEROCOLITIS; FEBRILE NEUTROPENIA; FEMALE; HEART DISEASE; HUMAN; INGUINAL LYMPH NODE; INTESTINE PERFORATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; NONHUMAN; OVERALL SURVIVAL; PELVIS EXENTERATION; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL (TOPIC); PROCTITIS; RADIOSENSITIZATION; RASH; RECTOVAGINAL FISTULA; RECURRENCE RISK; REVIEW; SEPSIS; SKIN DISEASE; VULVA CANCER; VULVA CARCINOMA; VULVECTOMY; WOUND HEALING IMPAIRMENT;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM STAGING; RECURRENCE; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 84858761517     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.04.008     Document Type: Review

References (116)

1. Jemal A., Center M.M., Ward E., Thun M.J. Cancer occurrence. Methods Mol Biol 2009, 471:3-29.
2. Beller U., Quinn M.A., Benedet J.L., et al. Carcinoma of the vulva. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006, 95(November (Suppl. 1)):S7-S27.
3. Piura B., Masotina A., Murdoch J., Lopes A., Morgan P., Monaghan J. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993, 48(February (2)):189-195.
4. Stang A., Streller B., Eisinger B., Jöckel K.H. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 2005, 96(January (1)):216-221.
5. Benedet J.L., Bender H., Jones H., Ngan H.Y., Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet 2000, 70(August (2)):209-262.
6. Pecorelli S., Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009, 108(May (2)):176.
7. Beller U., Maisonneuve P., Benedet J.L., et al. Carcinoma of the vulva. Int J Gynaecol Obstet 2003, 83(October (Suppl. 1)):7-26.
8. Hacker N.F., Berek J.S., Lagasse L.D., Leuchter R.S., Moore J.G. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983, 61(April (4)):408-412.
9. Podratz K.C., Symmonds R.E., Taylor W.F., Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983, 61(January (1)):63-74.
10. Homesley H.D., Bundy B.N., Sedlis A., et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva. Gynecol Oncol. 1993, 49(June (3)):279-283.
11. Creasman W.T., Phillips J.L., Menck H.R. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1997, 80(August 1 (3)):505-513.
12. Maggino T., Landoni F., Sartori E., et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer 2000, 89(July 1 (1)):116-122.
13. Knopp S., Tropè C., Nesland J.M., Holm R. A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice. J Clin Pathol 2009, 62(March (3)):212-218. [review].
14. Burrell M.O., Franklin E.W., Campion M.J., Crozier M.A., Stacy D.W. The modified radical vulvectomy with groin dissection: an eight-year experience. Am J Obstet Gynecol 1988, 159(September (3)):715-722.
15. Montana G.S. Carcinoma of the vulva: combined modality treatment. Curr Treat Options Oncol 2004, 5(April (2)):85-95.
16. Sardi J.E., Boixadera M.A., Sardi J.J. Neoadjuvant chemotherapy in cervical cancer: a new trend. Curr Opin Obstet Gynecol 2005, 17(February (1)):43-47.
17. Eddy J.L., Li J. Chemotherapy administration precaution. Oncol Nurs Forum 1986, 13(January-February (1)):9.
18. Payne J.K. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy. Oncol Nurs Forum 2002, 29(October (9)):1334-1340.
19. Kolb B.A., Buller R.E., Connor J.P., DiSaia P.J., Berman M.L. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 1992, 79:988-992.
20. Furey P.C., Macgillivray D.C., Castiglione C.L., Allen L. Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 1994, 55(March (3)):194-197.
21. Thomas G.M., Dembo A.J., Bryson S.C., Osborne R., DePetrillo A.D. Changing concepts in the management of vulvar cancer. Gynecol Oncol 1991, 42(July (1)):9-21.
22. Burke T.W., Stringer C.A., Gershenson D.M., Edwards C.L., Morris M., Wharton J.T. Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol 1990, 38(September (3)):328-332.
23. Siller B.S., Alvarez R.D., Conner W.D., et al. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy. Gynecol Oncol 1995, 57(June (3)):335-339.
24. Shimizu Y., Hasumi K., Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol 1990, 36(March (3)):423-427.
25. Durrant K.R., Mangioni C., Lacave A.J., et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol 1990, 37(June (3)):359-362.
26. Wagenaar H.C., Colombo N., Vergote I., et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001, 81:348-354.
27. Benedetti-Panici P., Greggi S., Scambia G., Salerno G., Mancuso S. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol 1993, 50:49-53.
28. Geisler J.P., Manahan K.J., Buller R.E. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006, 100:53-57.
29. Domingues A.P., Mota F., Durão M., Frutuoso C., Amaral N., de Oliveira C.F. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer 2010, 20(February (2)):294-298.
30. Narimatsu A., Okada O. A case of FIGO stage IV A vulvar cancer successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)]. Gan To Kagaku Ryoho 1997, 24(July (9)):1161-1165.
31. Boronow R.C., Hickman B.T., Reagan M.T., Smith R.A., Steadham R.E. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol 1987, 10(April (2)):171-181.
32. Van Doorn H.C., Ansink A., Verhaar-Langereis M., Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006, 3(July 19):CD003752.
33. Akl A., Akl M., Boike G., Hebert J., Graham J. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int J Radiat Oncol Biol Phys 2000, 48:415-420.
34. Berek J.S., Heaps J.M., Fu Y.S., Juillard G.J., Hacker N.F. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991, 42:197-201.
35. Carlson J.W., McGlennen R.C., Gomez R., Longbella C., Carter J., Carson L.F. Sebaceous carcinoma of the vulva: a case report and review of the literature. Gynecol Oncol 1996, 60(March (3)):489-491.
36. Cunningham M.J., Goyer R.P., Gibbons S.K., Kredentser D.C., Malfetano J.H., Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 1997, 66:258-261.
37. Han S.C., Kim D.H., Higgins S.A., Carcangiu M.L., Kacinski B.M. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000, 47:1235-1244.
38. Evans L.S., Kersh C.R., Constable W.C., Taylor P.T. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynaecologic malignancies. Int J Radiat Oncol Biol Phys 1988, 15(4):901-906.
39. Hruby G., MacLeod C., Firth I. Radiation treatment in recurrent squamous cell cancer of the vulva. Int J Radiat Oncol Biol Phys 2000, 46(March 15 (5)):1193-1197.
40. Iversen T. Irradiation and bleomycin in the treatment of inoperabile vulval carcinoma. Acta Obstet Gynecol Scand 1982, 61:195-197.
41. Jolicoeur M., Nguyen T.-V., Goffin F., et al. Conservative management of advanced or recurrent vulvar carcinoma. Int J Gynecol Cancer 2004, 14(Suppl. 1):52.
42. Kalra J.K., Grossman A.M., Krumholz B.A., et al. Preoperative chemoradiotherapy for carcinoma of the vulva. Gynecol Oncol 1981, 12(October (2 Pt 1)):256-260.
43. Koh W.J., Wallace H.J., Greer B.E., et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993, 26:809-816.
44. Levin W., Goldberg G., Altaras M., Bloch B., Shelton M.G. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol Oncol 1986, 25:20-25.
45. Lupi G., Raspagliesi F., Zucali R., et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996, 77:1472-1478.
46. Mäkinen J., Salmi T., Grönroos M. Individually modified treatment of invasive squamous cell vulvar cancer: 10-year experience. Ann Chir Gynaecol Suppl 1987, 202:68-71.
47. Pellegrino A., Fruscio R., Maneo A., et al. Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer. Int J Gynaecol Obstet 2008, 103(November (2)):185-188.
48. Raffetto N., Tombolini V., Santarelli M., Valeriani M., Galla D.A., Enrici R.M. Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva. Anticancer Res 2003, 23(May-June (3C)):3105-3108.
49. Roberts W.S., Kavanagh J.J., Greenberg H., et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower femalegenital tract. Gynecol Oncol 1989, 34(2):183-186.
50. Roberts W.S., Hoffman M.S., Kavanagh J.J., et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol 1991, 43(3):233-236.
51. Russell A.H., Mesic J.B., Scudder S.A., et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992, 47:14-20.
52. Sebag-Montefiore D.J., McLean C., Arnott S.J., et al. Treatment of advanced carcinoma of the vulvawith chemoradiotherapy-can exenterative surgery be avoided?. Int J Gynecol Cancer 1994, 4:150-155.
53. Thomas G., Dembo A., DePetrillo A., et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989, 34:263-267.
54. Wahlen S.A., Slater J.D., Wagner R.J., et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995, 75:2289-2294.
55. Scheistroen M., Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol 1993, 32:657-661.
56. Eifel P.J., Morris M., Burke T.W., Levenback C., Gershenson D.M. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 1995, 59:51-56.
57. Landoni F., Maneo A., Zanetta G., et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996, 61:321-327.
58. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998, 42:79-85.
59. Montana G.S., Thomas G.M., Moore D.H., et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 2000, 48:1007-1013.
60. Gadducci A., Cionini L., Romanini A., Fanucchi A., Genazzani A.R. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006, 60(December (3)):227-241.
61. Stehman F.B., Bundy B.N., Thomas G., et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992, 24(2):389-396.
62. Hacker N.F., Van der Velden J. Conservative management of early vulvar cancer. Cancer 1993, 71(February 15 (4 Suppl.)):1673-1677.
63. Homesley H.D. Management of vulvar cancer. Cancer. 1995, 76(November 15 (10 Suppl.)):2159-2170.
64. Magrina J.F., Gonzalez-Bosquet J., Weaver A.L., et al. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol 2000, 76(January (1)):24-27.
65. Origoni M., Sideri M., Garsia S., Carinelli S.G., Ferrari A.G. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 1992, 45(June (3)):313-316.
66. Podratz K.C., Symmonds R.E., Taylor W.F. Carcinoma of the vulva: analysis of treatment failures. Am J Obstet Gynecol 1982, 143(June 1 (3)):340-351.
67. Franklin E.W., Rutledge F.D. Prognostic factors in epidermoid carcinoma of the vulva. Obstet Gynecol 1971, 37(June (6)):892-901.
68. Homesley H.D., Bundy B.N., Sedlis A., et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 1993, 49(June (3)):279-283.
69. Homesley H.D., Bundy B.N., Sedlis A., Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986, 68(December (6)):733-740.
70. Fons G., Hyde S.E., Buist M.R., et al. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 2009, 19(October (7)):1276-1280.
71. Bellati F., Angioli R., Manci N., et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients withmultiple inguinal lymph node metastases. Gynecol Oncol 2005, 96:227-231.
72. Mulayim N., Foster Silver D., Schwartz P.E., Higgins S. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol 2004, 93:659-666.
73. Deppe G., Bruckner H.W., Cohen C.J. Adriamycin treatment of advanced vulvar carcinoma. Obstet Gynecol 1977, 50(July (1 Suppl.)):13s-14s.
74. Muss H.B., Bundy B.N., Christopherson W.A. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group Study. Am J Clin Oncol 1989, 12:142-144.
75. Witteveen P.O., van der Velden J., Vergote I., et al. Phase II, study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer - Gynaecological Cancer Group). Ann Oncol 2009, 20(September (9)):1511-1516.
76. Cormio G., Loizzi V., Gissi F., et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology 2009, 77(5):281-284.
77. Boabang P., Kurbacher C.M., Kohlhagen H., Waida A., Amo-Takyi B.K. Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using anATP-Tumor ChemosensitivityAssay. Anticancer Drugs 2000, 11:843-848.
78. Sirotnak F.M., Zakowski M.F., Miller V.A., Scher H.I., Kris M.G. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 2000, 6:4885-4892.
79. Olawaiye A., Lee L.M., Krasner C., Horowitz N. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol 2007, 106(September (3)):628-630. [Epub 2007, Junuary 11].
80. Horowitz N., Olawiye A., Growdon W., et al. Phase II trial of erlotinib (Tarceva) in women with squamous cell carcinoma of the vulva. Gynecol Oncol 2010, 116:S14. [abstract].
81. Richard S.D., Krivak T.C., Beriwal S., Zorn K.K. Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab. Int J Gynecol Cancer 2008, 18(September-October (5)):1132-1135. [Epub 2007, November 16].
82. Li X., Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 2010, 70(July 15 (14)):5942-5952.
83. Shih T., Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 2006, 28(November (11)):1779-1802.
84. Monk B.J., Sill M.W., Burger R.A., Gray H.J., Buekers T.E., Roman L.D. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2009, 27(March 1 (7)):1069-1074. [Epub 2009, January 12].
85. Bamberger E.S., Perrett C.W. Angiogenesis in benign, pre-malignant and malignant vulvar lesions. Anticancer Res 2002, 22(November-December (6C)):3853-3865. [review].
86. Hantschmann P., Jeschke U., Friese K. TGF-alpha, c-erbB-2 expression and neoangiogenesis in vulvar squamous cell carcinoma. Anticancer Res 2005, 25(May-June (3A)):1731-1737.
87. Manchana T., Ittiwut C., Mutirangura A., Kavanagh J.J. Targeted therapies for rare gynaecological cancers. Lancet Oncol 2010, 11(July (7)):685-693. [Epub 2010, March 31].
88. Leiserowitz G.S., Russell A.H., Kinney W.K., Smith L.H., Taylor M.H., Scudder S.A. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 1997, 66(September (3)):509-514.
89. Hallak S., Ladi L., Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007, 31(November (5)):1077-1085.
90. Acosta A.A., Given F.T., Frazier A.B., Cordoba R.B., Luminari A. Preoperative radiation therapy in the management of squamous cell carcinoma of the vulva: preliminary report. Am J Obstet Gynecol 1978, 132:198-206.
91. Hacker N.F., Berek J.S., Juillard G.J., Lagasse L.D. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer 1984, 54:2056-2061.
92. Rotmensch J., Rubin S.J., Sutton H.G., et al. Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. Gynecol Oncol 1990, 36:181-184.
93. Byfield J.E., Calabro-Jones P., Klisak I., Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays. Int J Radiat Oncol Biol Phys 1982, 8:1923-1933.
94. Nigro N.D., Vaitkevicius V.K., Buroker T., Bradley G.T., Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981, 24:73-75.
95. Cummings B., Keane T., Thomas G., Harwood A., Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 1984, 54:2062-2068.
96. Gerszten K., Selvaraj R.N., Kelley J., Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005, 99:640-644.
97. Morley GW Infiltrative carcinoma of the vulva: results of surgical treatment. Am J Obstet Gynecol 1976, 124(April 15 (8)):874-888.
98. Beriwal S., Coon D., Heron D.E., et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Oncology 2008, 109(May (2)):291-295.
99. Jaakkola M., Rantanen V., Grenman S., Kulmala J., Grenman R. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Cancer 1996, 77:1940-1946.
100. Jaakkola M., Rantanen V., Grenman S., Kulmala J., Grenman R. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro. Anticancer Res 1997, 17:939-943.
101. Raitanen M., Rantanen V., Kulmala J., et al. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines. Int J Cancer 2002, 97:853-857.
102. Raitanen M., Rantanen V., Kulmala J., Helenius H., Grenman R., Grenman S. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro. Int J Cancer 2002, 100:238-243.
103. Tans L., Ansink A.C., van Rooij P.H., Kleijnen C., Mens J.W. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2010, (January):15.
104. Rogers L.J., Howard B., Van Wijk L., et al. Chemoradiation in advanced vulval carcinoma. Int J Gynecol Cancer 2009, 19(May (4)):745-751.
105. Peh W.C., Khong P.L., Sham J.S., Ho W.Y., Yeung H.W. Sacral and pubic insufficiency fractures after irradiation of gynaecological malignancies. Clin Oncol (R Coll Radiol) 1995, 7(2):117-122.
106. Salom E.M., Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 2002, 3(April (2)):143-153.
107. Thigpen J.T., Blessing J.A., Homesley H.D., Lewis G.C. Phase II, trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study. Gynecol Oncol 1986, 23(March (3)):358-363.
108. Luckett T., King M., Butow P., Friedlander M., Paris T. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer 2010, 20(May (4)):664-684.
109. Edwards C.L., Tortolero-Luna G., Linares A.C., et al. Vulvar intraepithelial neoplasia and vulvar cancer. Obstet Gynecol Clin North Am 1996, 23(June (2)):295-324.
110. Piura B., Egan M., Lopes A., Monaghan J.M. Malignant melanoma of the vulva: a clinicopathologic study of 18 cases. J Surg Oncol 1992, 50(August (4)):234-240.
111. Piura B., Rabinovich A., Dgani R. Malignant melanoma of the vulva: report of six cases and review of the literature. Eur J Gynaecol Oncol 1999, 20(3):182-186.
112. Sugiyama V.E., Chan J.K., Shin J.Y., Berek J.S., Osann K., Kapp D.S. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007, 110(August (2 Pt 1)):296-301.
113. Harting M.S., Kim K.B. Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. Melanoma Res 2004, 14(December (6)):517-520.
114. Piura B., Meirovitz M., Kedar I. Long-term disease-free survival following surgery and active specific immunotherapy with allogeneic vaccine in a patient with high-risk malignant melanoma of the vulva. Eur J Obstet Gynecol Reprod Biol 1998, 81(October (1)):83-85.
115. Chemo- and Radiotherapy in Epithelial Vulvar Cancer (CARE). AGO Study Group. http://clinicaltrials.gov/.
116. Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva. European Organization for Research and Treatment of Cancer. http://clinicaltrials.gov/.